Longmen Capital
Zhuhai, Guangdonglongmencapital.com
Overview
Longmen Capital is a venture capital firm specializing in the healthcare industry, focusing on innovative medicine research and early-stage investments. The team members have medical or biological backgrounds and many years of industry experience. Since its establishment in 2017, Longmen Capital has invested in more than 40 pharmaceutical innovation companies, with a fund management scale of over 2 billion yuan. Longmen Capital adheres to the principle of independent research and value discovery and aims to promote the industrialization of scientific and technological achievements with capital.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Ractigen Therapeutics | Jul 2026 | Early Funding | Co-investor |
| Qure Biotechnology (Shanghai) Co., Ltd. | Dec 2021 | Series B | Co-investor |
| Moore Thread | Nov 2021 | Series A | - |
| Aratek Biometrics | Oct 2021 | Series B | Co-investor |
| Hopstem Biotechnology | May 2021 | Series A Extension | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
